Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia

Clinical trial NCT03654768 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT03654768

Sponsor

SWOG Cancer Research Network

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2018-10-24

Primary completion

2024-07-01

Enrollment

81

View on ClinicalTrials.gov